Skip to content

Survey the effect of magnesium on coagulopathy of liver transplant patients.

The effect of magnesium sulfate on coagulation parameters of the ROTEM system during adult liver transplant anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016012911662N9
Enrollment
60
Registered
2016-01-30
Start date
2015-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplantation. Surgical operation with transplant of whole organ

Interventions

Intervention 1: Each patient in the intervention group , will received 1.5 gram magnesium sulfate that will be diluted with normal saline up to 50 ml with 50 ml syringe with B label that will be in
Treatment - Drugs
Placebo
Each patient in the intervention group , will received 1.5 gram magnesium sulfate that will be diluted with normal saline up to 50 ml with 50 ml syringe with B label that will be infused intravenou
Each patient in the control group, will receive 50 ml normal saline in 50 ml syringe with A label that will be infused intravenously in 5 minutes.

Sponsors

Vice-Chancellery of Research and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The eligible participants were all patients with end stage liver disease aged between 18 and 60 years old, who were candidates for orthotopic liver transplantation under general anesthesia. Exclusion criteria were: having a history of hepatorenal syndrome types ? and ??; baseline serum potassium >6 meq/l; ejection fraction <60% and cirrhotic cardiomyopathy and patients with INR <1.5.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Measurement of the coagulation profiles on rotational thromboelastometry (ROTEM) system. Timepoint: First time, before magnesium sulfate infusion and induction of anesthesia and second time, after magnesium sulfate infusion just before surgical incision. Method of measurement: By rotational thromboelastometry (ROTEM) system.

Secondary

MeasureTime frame
Measurement of the serum magnesium level. Timepoint: First time, before magnesium sulfate infusion and induction of anesthesia and second time, after magnesium sulfate infusion just before surgical incision. Method of measurement: In the lab by special kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ali Sahmeddini

Shiraz University Of Medical Sciences

sahmeddini@sums.ac.ir+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026